WIZARD and the design of trials for secondary prevention of atherosclerosis with antibiotics.
about
Inclusion fluorescent-antibody test as a screening assay for detection of antibodies to Chlamydia pneumoniae.Should antibiotics now be part of routine treatment of coronary heart disease?Current approaches to therapy for vascular injury.Role of antibiotics for the prevention of cardiovascular disease.Antibiotic trials for coronary heart disease.Update of antibiotic trials for secondary prevention of coronary heart disease.
P2860
WIZARD and the design of trials for secondary prevention of atherosclerosis with antibiotics.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
WIZARD and the design of trial ...... erosclerosis with antibiotics.
@ast
WIZARD and the design of trial ...... erosclerosis with antibiotics.
@en
type
label
WIZARD and the design of trial ...... erosclerosis with antibiotics.
@ast
WIZARD and the design of trial ...... erosclerosis with antibiotics.
@en
prefLabel
WIZARD and the design of trial ...... erosclerosis with antibiotics.
@ast
WIZARD and the design of trial ...... erosclerosis with antibiotics.
@en
P1476
WIZARD and the design of trial ...... erosclerosis with antibiotics.
@en
P2093
P304
P356
10.1016/S0002-8703(99)70297-8
P407
P433
P577
1999-11-01T00:00:00Z